ITT Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Luca Savi
- Full Time Employees
- 11,600
- Sector
- Industrials
- Industry
- Industrial - Machinery
- Address
- 100 Washington Boulevard Stamford CT United States of America 06902
- IPO Date
- Dec 15, 1995
- CIK
- 0000216228
- Website
- itt.com
- Similar Companies
- Business
- ITT Inc. engineers and provides essential components and bespoke technological offerings across global transportation, industrial, and energy sectors. The company operates through three principal divisions: Motion Technologies, Industrial Process, and Connect & Control Technologies. The Motion Technologies segment develops and manufactures friction materials, brake pads, advanced shock absorbers, and various energy absorption and damping solutions. These products serve a wide array of applications within the transportation industry, encompassing passenger vehicles, commercial trucks, heavy-duty and military transport, buses, and railway systems. Brands such as KONI shock absorbers and Axtone energy absorption solutions are prominent in this segment. In a strategic portfolio adjustment, the company divested its Wolverine Advanced Materials business in mid-2024. The Industrial Process division focuses on designing and producing a comprehensive suite of fluid handling and control equipment. Its offerings include industrial pumps, such as centrifugal, twin-screw, and multiphase models under brands like Goulds Pumps and Bornemann, alongside a variety of valves and sophisticated plant optimization and remote monitoring systems. This segment also delivers extensive aftermarket support, including replacement components and services, for diverse industries such as chemical, energy, mining, biopharmaceutical, and other industrial process markets. The acquisition of Svanehøj in early 2024 further expanded its capabilities in critical liquid and cryogenic pump technologies. The Connect & Control Technologies segment specializes in creating a wide range of highly engineered connectors and critical control components. These solutions cater to demanding applications in aerospace and defense, general industrial, medical, and energy markets. Its product portfolio features various electrical and fiber optic connectors, alongside control items like actuators, specialized valves, and switches for flow control, as well as rate controls, seat recline mechanisms, and elastomeric isolators for aircraft interiors. Additionally, this segment provides heaters, hoses, composite ducting for environmental control, and advanced composite materials for engine applications. In 2024, the company enhanced this segment through the acquisition of kSARIA, an interconnect solutions provider. ITT Inc. was established in 1920 and maintains its corporate headquarters in Stamford, Connecticut.
California Public Employees Retirement System Buys 11,078 Shares of ITT Inc. $ITT
Bank of New York Mellon Corp Reduces Stake in ITT Inc. $ITT
Assetmark Inc. Raises Holdings in ITT Inc. $ITT
Allspring Global Investments Holdings LLC Has $21.26 Million Position in ITT Inc. $ITT
CIB vs. ITT: Which Stock Is the Better Value Option?
ITT to Release Second Quarter 2026 Results on Thursday, August 6
ITT Completes Acquisition of Aerospace Contacts LLC
ITT Stock Gains From Business Strength Amid Persisting Headwinds
Here's Why You Should Hold ITT Stock in Your Portfolio Now
MARUY vs. ITT: Which Stock Is the Better Value Option?
ITT Announces Appointment of Bertrand Loy and Kevin Wheeler to Board of Directors
ITT (ITT) Stock Jumps 3.0%: Will It Continue to Soar?
ITT Expands Product Portfolio Through Aerospace Contacts Acquisition
Are Conglomerates Stocks Lagging ITT (ITT) This Year?
ITT Signs Agreement to Acquire Aerospace Contacts LLC, A Leading Provider of Specialized, High-Reliability Contacts
MARUY vs. ITT: Which Stock Should Value Investors Buy Now?
Caliway Unveils Latest OI25 Animal Study Data for CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies at ADA 2026, Demonstrating Dual Potential to Attenuate Post-Discontinuation Weight Rega
Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer
Neurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of NGN-401 for Rett Syndrome
Is ITT (ITT) Stock Outpacing Its Conglomerates Peers This Year?